← Leaderboards
Sara McCoy
University Of Wisconsin-Madison
$2,157,896
Attributed
$2,761,962
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,761,962 · 5
By mechanism
R01$1,386,899 · 1
R21$766,383 · 2
R03$311,000 · 1
R34$297,680 · 1
Top collaborators
- Ahmet F. Coskun3 shared
- Randall J Kimple2 shared
- Maria Virumbrales Munoz1 shared
Others in their field
Other Rising Stars on “Innovation”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Mari Ostendorf · University Of Washington$51,931,230
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Cyrus Wadia · Activate Global, Inc.$31,489,493
Research focus
InnovationCellsSalivary GlandsAffectClinical TrialsFda ApprovedS SyndromeSystemic Autoimmune DiseaseOral CharactersPathogenesisFutureSjogren&AposSalivary Gland DiseasesIn VivoB-LymphocytesGenetic TranscriptionInflammatoryIn VitroMissionMesenchymal Stromal CellPhenotypeMorbidity - Disease RateCytokineTechnology
Grant awards (9)
Defining Sjögrenâs pathogenesis by endotype: maladaptive responses of endogenous salivary gland mesenchymal stromal cells$686,512
R01 · FY2025 · DE · contact PI
Microphysiological systems to recapitulate and interrogate Sjögrenâs disease salivary gland pathogenesis$432,209
R21 · FY2025 · DE · contact PI
Defining Sjögrenâs pathogenesis by endotype: maladaptive responses of endogenous salivary gland mesenchymal stromal cells$700,387
R01 · FY2024 · DE · contact PI
Spatial transcriptional phenotyping of Sjögrenâs disease tissue-resident mesenchymal stromal cells and neighbors in labial salivary glands$180,122
R21 · FY2024 · DE
Planning a phase I study of minor salivary gland derived autologous MSCs for prevention of long-term radiation induced xerostomia$147,680
R34 · FY2024 · DE
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome$155,500
R03 · FY2023 · DE · contact PI
Spatial transcriptional phenotyping of Sjögrenâs disease tissue-resident mesenchymal stromal cells and neighbors in labial salivary glands$154,052
R21 · FY2023 · DE
Planning a phase I study of minor salivary gland derived autologous MSCs for prevention of long-term radiation induced xerostomia$150,000
R34 · FY2023 · DE
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome$155,500
R03 · FY2022 · DE · contact PI